Valuation check: IQV's profit margin is 8.1%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for IQV is 8.1% as of June 2026. That compares with 7.88% in the prior-year period — up 2.8% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside IQVIA Holdings's historical trend and sector peers before judging valuation or financial health.
Over the past year, IQV's profit margin moved from 7.88% to 8.1% — a 2.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in IQVIA Holdings's valuation or profitability profile.
Against Healthcare companies, IQV currently prints 8.1% for profit margin, while the sector average sits near 14.34%. That is roughly 43.6% below the sector mean. Large gaps often invite a closer look at IQVIA Holdings's growth, margins, and balance sheet.
Profit Margin shows how effectively IQVIA Holdings converts resources into returns. At 8.1%, IQV may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 7.88% in the prior-year period — up 2.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting IQV's profit margin (8.1%), review year-over-year change from 7.88%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.